Exploring the Projects, Partnerships and Capital Driving Arizona’s Emergence as a National Bioscience Leader — And How CRE Professionals Can Capitalize on the Next Phase of Growth

What You’ll Learn From CRE Leaders At This Event:

• What market fundamentals make Greater Phoenix one of the top four life sciences job growth markets in the U.S., and how sustainable is this momentum?
• As new bioscience hubs emerge nationally, what distinct value propositions can Phoenix offer to companies and researchers choosing between markets like Boston, San Diego or the Bay Area?
• What design principles are emerging as must-haves for life sciences real estate in Phoenix, from vertically integrated outpatient campuses to hyper-connected R&D districts?
• Arizona bioscience companies secured $289 million in VC funding in 2024, nearing a record high, though the number of deals declined. How are investors adjusting their strategies, and what factors now matter most when deciding which companies to back?
• What milestones should Phoenix’s life sciences community collectively aim for to cement its place among top-tier U.S. bioscience markets?